Home›Stock Screener›Vaishali Pharma›Financial Statements

Vaishali Pharma Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Vaishali Pharma (VAISHALI) reported revenue ₹28 Cr, net profit ₹0 Cr and EPS ₹0.03. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Vaishali Pharma shareholding analysis to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

EBITDA Margin 3.57% 2026 data
Operating Margin -1.00% 2026 data

Balance Sheet Ratios

Current Ratio 18.83 2026 data
Equity Ratio 56.10% 2026 data
Asset Turnover 0.23 2026 data

VAISHALI Revenue, Net Profit & EBITDA — Year-on-Year Growth

VAISHALI YoY (Sept 2025 vs Mar 2026) — revenue -17.6%, net profit -100.0%, EBITDA -50.0%, expenses -15.6%. For live price, earnings ratios and company overview, see Vaishali Pharma screener.

Revenue Growth
-17.6%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-50.0%
Year-over-Year
Expense Growth
-15.6%
Year-over-Year
Assets Growth
+11.8%
Year-over-Year
Equity Growth
+6.2%
Year-over-Year
Operating Cash Flow Growth
-1900.0%
Year-over-Year
Investing Cash Flow Growth
-100.0%
Year-over-Year
Financing Cash Flow Growth
+2000.0%
Year-over-Year

VAISHALI Income Statement — Revenue, EBITDA & Net Profit

Vaishali Pharma revenue ₹28 Cr, EBITDA ₹1 Cr, net profit ₹0 Cr, EPS ₹0.03 (2026). Examine Vaishali Pharma quarterly financials for recent quarterly revenue, profit and EPS trends.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Jun 2025 Dec 2025
Revenue 28 34 25 26
Expenses 27 32 22 23
EBITDA 1 2 2 2
Operating Profit Margin % -1.00% 4.00% 6.00% 6.00%
Depreciation 0 0 0 0
Interest 1 0 0 1
Profit Before Tax 0 2 2 2
Tax 0 1 1 1
Net Profit 0 1 1 1
Earnings Per Share (₹) 0.03 0.09 0.10 0.10

VAISHALI Balance Sheet — Assets, Liabilities & Shareholders' Equity

VAISHALI total assets ₹123 Cr, total equity ₹69 Cr, total liabilities ₹ Cr (2026).

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
ASSETS
Total Assets 123 110 80 79 82 86 66 69 64 45
Current Assets 113 105 75 73 76 81 61 63 59 40
Fixed Assets 2 2 2 2 1 1 2 1 1 1
Capital Work in Progress 0 0 1 1 1 0 0 0 0 0
Investments 3 0 0 0 0 0 0 0 0 0
Other Assets 0 107 77 76 80 84 64 67 62 43
LIABILITIES
Total Liabilities
Current Liabilities 6 5 4 6 3 4 4 5 3 4
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 69 65 43 41 26 22 21 21 21 4
Share Capital 26 26 11 11 11 11 11 7 7 3
Reserves & Surplus 43 39 32 30 16 12 11 15 14 1

VAISHALI Cash Flow Statement — Operating, Investing & Financing

Vaishali Pharma operating cash flow ₹-18 Cr, investing ₹0 Cr, financing ₹19 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -18 1 1 1 2 3 4 -10 1 5 -4
Investing Activities 0 1 0 -1 0 0 0 1 1 3 2
Financing Activities 19 -1 -2 0 -2 -3 -4 9 -1 -8 2
Net Cash Flow 0 1 0 1 0 0 0 0 0 0 0